Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dissecting Aneurysm of the Thoracic Aorta”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05754736
What this trial is testing

Clinical Study of Ametinib Combined With Bevacizumab in First-line Treatment of Advanced NSCLC With EGFR-mutations.

Who this might be right for
Non-small Cell Lung Cancer
The Second Affiliated Hospital of Shandong First Medical University 50
Large-scale testing (Phase 3)Study completedNCT02491671
What this trial is testing

Effectiveness Novel Tissue Sealant, Prevention Prolonged Air Leak (PAL) After Lung Resection

Who this might be right for
Prolonged Air LeakLung Resection
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León 260
Testing effectiveness (Phase 2)UnknownNCT04427787
What this trial is testing

A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET

Who this might be right for
Metastatic Well Differentiated Neuroendocrine NeoplasmNeuroendocrine Tumors
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 69
Early research (Phase 1)Study completedNCT03667716
What this trial is testing

COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

Who this might be right for
Advanced CancerOvarian CancerBreast Cancer+7 more
Compugen Ltd 121
Not applicableLooking for participantsNCT07338006
What this trial is testing

Chest Wall Reconstruction Cohort

Who this might be right for
Chest Wall TumorReconstructive Surgical ProcedureMalignancy
University of Health Sciences Lahore 50
Very early researchStudy completedNCT04298606
What this trial is testing

A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence

Who this might be right for
Chronic Obstructive Pulmonary DiseaseLung Non-Small Cell CarcinomaPneumonia+5 more
Roswell Park Cancer Institute 20
Not applicableNot Yet RecruitingNCT07644104
What this trial is testing

Efficacy and Safety of the Visual Bronchial Blocker for Lung Isolation Surgery

Who this might be right for
Thoracic Surgery With One-lung VentilationLung IsolationBronchial Blockage+1 more
Zhejiang University 652
Not applicableUnknownNCT05400304
What this trial is testing

Radiomics Combined With Frozen Section Prediction Model for Spread Through Air Space in Lung Adenocarcinoma

Who this might be right for
Lung Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 900
Testing effectiveness (Phase 2)Ended earlyNCT02002052
What this trial is testing

Functional Lung Avoidance for Individualized Radiotherapy (FLAIR): A Randomized, Double-Blind Clinical Trial

Who this might be right for
Non-small Cell Lung Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 29
Not applicableStudy completedNCT03354767
What this trial is testing

The Role of Ischaemia-reperfusion Injury in the Pathogenesis of Muscle Wasting After Thoracic Aortic Surgery

Who this might be right for
Muscular Diseases
Imperial College London 40
Testing effectiveness (Phase 2)Ended earlyNCT00503971
What this trial is testing

Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.

Who this might be right for
Non-small Cell Lung Cancer
Spanish Lung Cancer Group 33
Not applicableNot Yet RecruitingNCT07805434
What this trial is testing

AI-Based Personalized Digital Management for High-Risk Pulmonary Nodule Follow-up

Who this might be right for
Pulmonary Nodules
The First Affiliated Hospital of Guangzhou Medical University 4,000
Not applicableStudy completedNCT04654234
What this trial is testing

Total-body PET/CT Imaging Using the uEXPLORER in Non-small Cell Lung Cancer Patients Treated by Induction Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiotherapy

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 15
Testing effectiveness (Phase 2)Looking for participantsNCT05940532
What this trial is testing

A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hunan Cancer Hospital 41
Not applicableStudy completedNCT03301493
What this trial is testing

Genomic Testing and Resulting Medical Decisions

Who this might be right for
Cancer of Unknown OriginCancer RefractoryCancer of Stomach+12 more
Arbeitsgemeinschaft medikamentoese Tumortherapie 1,500
Early research (Phase 1)Study completedNCT00575393
What this trial is testing

Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Mayo Clinic 17
Not applicableStudy completedNCT04996693
What this trial is testing

On Dose Efficiency of Modern CT-scanners in Chest Scans

Who this might be right for
PneumoniaLung CancerPulmonary Embolism+2 more
University Hospital Augsburg 958
Not applicableUnknownNCT00155116
What this trial is testing

SERPIN D1 and Its Role in Lung Cancer Invasion and Metastasis

Who this might be right for
Non-Small Cell Lung Cancer
National Taiwan University Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT06393816
What this trial is testing

FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum

Who this might be right for
Large Cell Neuroendocrine Carcinoma of the Lung
Centre Leon Berard 80
Not applicableUnknownNCT02063633
What this trial is testing

PET With Respiratory Gating Technique in Evaluation of Response and Normal Tissue Effect in Thoracic Cancer

Who this might be right for
To Correlate RPM Respiratory-gating Methods Analyses, Treatment Response, and Normal Tissue Metabolic Effect.Application in Clinical Outcomes and Prediction of Prognosis.
Far Eastern Memorial Hospital 30
Next Page